Contact
Kristina Dinger
Head of People
career@adragos-pharma.com
About us
We are a globally operating Contract Development and Manufacturing Organisation (CDMO) headquartered in Germany. Our sites in Germany, France, Greece and Japan focus on the development and manufacturing of drug products (FDF) in the small molecule segment. Our manufacturing sites cover relevant technologies in sterile liquids, non-sterile liquids, and semi-solids, providing end-to-end services for our large base of (bio)pharma customers. Our development site in Greece is a one-stop shop for our partners offering a range of services to take products from inception to MA grant and supply.
Adragos Pharma was founded in 2020 pursuing an ambitious Buy&Build growth strategy, partnering with Scandinavian PE, FSN Capital, and a leading German Family Office, Prange Group. We grew the team from three to more than 700 people and will acquire and integrate even more pharmaceutical production sites in Europe and North America to become a market leader in the CDMO segment.
CDMOs (Contract Development and Manufacturing Organization), produce approx. 25% of drugs that are available in pharmacies and clinics, thus playing a vital role in medication access for millions of patients globally. Due to the increasing pressure on healthcare systems (aging population, prevalence of chronic disease, etc.), the importance of CDMOs is only going to grow.
You want to be part of our dynamic growth? Then apply now!